의료기기의 판매 계약(2016-2026년)

Benchmark Global Distribution Partnerships Across the Medical Device Industry

This latest Distribution Deals in Medical Devices report provides a comprehensive analysis of distribution partnerships across the global medical device sector. Designed for business development, licensing, and commercial strategy professionals, the report delivers detailed insight into how companies structure distribution agreements, negotiate financial terms, and expand market access through strategic partnerships.

Fully revised and updated, the report examines distribution deals announced between 2016 and 2026, providing a clear view of how device manufacturers collaborate with distribution partners to reach new markets and accelerate commercialization.

The report contains a comprehensive listing of distribution deals recorded in the Current Agreements deals and alliances database, including financial terms where available and links to online deal records. Where agreements have been publicly filed, the report also provides access to the underlying contract documents submitted to the SEC, enabling deeper insight into how distribution partnerships are structured in practice.

Whether you are benchmarking deal structures, identifying distribution partners, or performing due diligence on commercialization strategies, this report provides the real-world deal data and contract intelligence needed to structure stronger distribution agreements.

Key Benefits

• Save Significant Research Time

Access a consolidated database of distribution deals instead of searching multiple press releases, databases, and regulatory filings.

• Benchmark Distribution Deal Structures

Understand how medical device companies structure distribution partnerships, including territorial rights, commercialization responsibilities, and operational roles.

• Analyze Financial Deal Terms

Review disclosed payment structures and commercial terms to benchmark the financial structure of comparable distribution partnerships.

• Access Real Contract Documents

Where available, explore SEC-filed distribution agreements, providing insight into the detailed contractual provisions behind real-world partnerships.

• Identify the Most Active Distribution Dealmakers

Discover which companies are leading distribution partnerships across the medical device sector and analyze their commercialization strategies.

• Track Industry Trends

Analyze distribution deal activity since 2016 across companies, therapeutic areas, and technology segments to understand how device commercialization strategies are evolving.

What's Included in the Report

Analysis of distribution dealmaking trends since 2016

Overview of distribution partnership structures and financial models

Review of leading distribution deals by disclosed value

Profiles of the most active distribution dealmakers

Detailed analysis of deals organized by company, therapeutic area, and technology type

A comprehensive directory of distribution deals recorded in the Current Agreements database

Links to online deal records and contract documents where available

Due Diligence Insights from Real Agreements

By reviewing actual distribution contracts, the report allows users to evaluate key partnership provisions such as:

• Territorial distribution rights
• Commercial responsibilities between partners
• Payment structures and commercial terms
• Exclusivity provisions
• Supply and commercialization obligations
• Contract duration and termination provisions
• Why This Report Matters
• Distribution partnerships are critical to the global commercialization of medical devices, enabling companies to expand market reach, accelerate product launches, and access regional expertise.
• By combining comprehensive deal data, financial benchmarking, and access to real contract documents, this report provides the intelligence needed to structure stronger distribution partnerships and negotiate more effectively.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in distribution dealmaking

• 2.1. Introduction
• 2.2. Definition of distribution deal
• 2.3. Trends in distribution deals since 2016
  • 2.3.1. Distribution dealmaking by year
  • 2.3.2. Distribution dealmaking by phase of development
  • 2.3.3. Distribution dealmaking by therapy area
  • 2.3.4. Distribution dealmaking by technology type
  • 2.3.5. Distribution dealmaking by most active company
  • 2.3.6 Attributes of pure distribution deals
  • 2.3.7 Attributes of distribution in multi-component deals
• 2.4. Aligning partners to make the distribution agreement work

Chapter 3 - Overview of distribution deal structure

• 3.1. Introduction
• 3.2. Distribution agreement structure
• 3.3 Distribution rights as part of a wider alliance agreement

Chapter 4 - Leading distribution deals

• 4.1. Introduction
• 4.2. Top distribution deals by value

Chapter 5 - Top 25 most active distribution dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active distribution dealmakers
• Deal directory
• Deal directory - distribution dealmaking by companies A-Z
• Deal directory - distribution dealmaking by therapy area
• Deal directory - distribution dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of distribution
• Figure 2: Trends in distribution deal announcements
• Figure 3: Distribution deals signed at each phase of development
• Figure 4: Distribution deals by therapy area
• Figure 5: Distribution deals by technology type
• Figure 6: Top 25 most active distribution dealmakers
• Figure 7: Issues in implementing distribution agreements
• Figure 8: Distribution agreements - what should a contract include?
• Figure 9: Components of the distribution deal structure
• Figure 10: Top distribution deals by value
• Figure 11: Most active distribution dealmakers